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Figure 1: Overview of DPVis. It allows users to gain clinical insights into observational data using various views.
ABSTRACT
A goal of clinical researchers is to understand the progression of
a disease through a set of biomarkers. Researchers often conduct
observational studies, where they collect numerous samples from
selected subjects throughout multiple years. Hidden Markov Models
(HMMs) can be applied to discover latent states and their transi-
tion probabilities over time. However, it is challenging for clinical
researchers to interpret the outcomes and to gain insights about
the disease. Thus, this demo introduces an interactive visualization
system called DPVis, which was designed to help researchers to inter-
actively explore HMM outcomes. The demo provides guidelines of
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how to implement the clinician-in-the-loop approach for analyzing
longitudinal, observational health data with visual analytics.
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1 MOTIVATION
Clinical researchers want to characterize patterns of disease develop-
ment by using a set of biomarkers. Therefore, they conduct obser-
vational studies to collect samples from selected patients through-
out multiple years. Large-scale prospective clinical studies make
it possible for clinicians to collect serial lab tests, self-reports, and
treatments over a long period of time. The collected data can lead
to an understanding of disease progression trajectories of multiple
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patients. A major challenge is to find appropriate methods that dis-
till temporal sequences of various measures into clinically useful
insights.
One approach for modeling disease progression is to describe a
patient’s clinical course as a series of transitions between a small
number of states, with each state describing a co-occurring pattern of
observed measures or symptoms [4]. The states, commonly referred
to as latent or hidden variables, are not directly observed but rather
must be discovered from the data. Hidden Markov models (HMMs)
are a class of unsupervised, statistical models that allow for discov-
ering such latent states, understanding characteristics of progression
patterns with the associated observed variables for corresponding
states, and predicting a patient’s future states. Since HMMs can be
trained on longitudinal patient data from large-scale clinical studies
and electronic health records (EHRs), HMMs have been success-
fully applied to capture heterogeneous disease progression patterns
in various disease, such as chronic obstructive pulmonary disease [4]
and Huntington’s disease [3].
Despite the potential usefulness of HMMs for understanding
disease progression patterns, it remains challenging for clinical re-
searchers to make sense of the models and to derive useful insights
about the disease. Goals of data exploration include discovery of
heterogeneous disease progression patterns, observation of interac-
tions between such patterns and patients’ characteristics, and testing
and refining hypotheses for multiple cohorts in an adhoc manner.
HMMs can produce relevant outputs that can potentially fulfill these
needs, but it is often difficult for clinical researchers to gain useful
understanding of clinical observation data by aggregating and con-
necting various outcomes without the help of interactive visualiza-
tion systems. Though prior studies introduced inspiring visualization
techniques that can partially solve these problems, no system yet
integrates such techniques into a visual analytic solution for disease
progression modeling using HMMs.
Thus, this demo introduces a visual analytic system called DPVis
[2] that integrates HMM outcomes on observational data with inter-
active visualizations. This study demonstrates the usefulness of the
visual analytics approach by summarizing design and application
of DPVis to observational data from birth-cohort studies of Type 1
Diabetes (T1D). It provides useful guidelines of how to implement
the clinician-in-the-loop approach for gaining clinically meaningful
insights into longitudinal, observational health data.
2 DPVIS
This section describes how the design of DPVis allows clinical
researchers to interpret HMMs and to gain clinical insights. The
following sections illustrate how each view allows users to interpret
HMM outcomes and to use them for understanding the disease
progression patterns. Full details of DPVis including a video can be
found: https://bckwon.com/publication/dpvis.
The tool is developed using Javascript, HTML, and CSS for the
front end and Python for the back end. The team of researchers is
actively working on deploying the tool on the web so that other
clinical researchers can use the tool. Currently, the tool requires
users to train a HMM model on longitudinal data with no personally
identifiable information, where each row represents a patient’s visit
to a clinic. Then, the output includes additional columns, which
show an inferred state and posterior probabilities per each visit. We
use a model trained with a type 1 diabetes dataset to illustrate the
views of visualizations (see more details of the model in the previous
paper [1].
2.1 State Summary
Feature Matrix summarizes the hidden states of HMMs by showing
probabilities of selected variables per state as Figure 1 shows. The
view shows the probabilities of variables in text and intensity of
colors with a heatmap. By using this approach, users can understand
the characteristics of states based on the variables while interacting
with other views. For instance, Figure 1 shows probabilities of three
islet autoantibodies (IAs) for 11 states discovered by a trained model.
Researchers can find that States 0, 3, and 8 presents the state without
any IAs (low values in blue for all three rows on top). The three states
represent initial states, which indicate that the model discovered
three distinctive trajectories starting from each of the three states.
The view also provides probabilities of other variables that are not
used in HMMs, which can provide useful insights for steering the
model with additional variables. Feature Matrix is useful to remind
clinical researchers of what the states represent which can be helpful
to interpret state transitions in Pathway Waterfall.
2.2 State Transition Summary
Pathway Waterfall shows subjects’ state transition patterns using
parallel beeswarm visualizations for subjects’ visits overlaid with
lines for their trajectories, as Figure 1 shows. Each dot represents a
subject’s visit, which is horizontally positioned for the subject’s age
and vertically positioned for the state discovered for the particular
visit. Trajectory lines are drawn to connect subject’s visits, which
show the state transition pathways over subjects’ age. Using this
view, clinical researchers can view the distribution of visits over time
per state. In addition, they can also gain insights into the heteroge-
neous state transition patterns over time by viewing bundled paths
and following the trajectories. Figure 1 shows the overview of state
transition pathways and the characteristics of states for a particular
subcohort, which follows transitions from state 3 through 6 step by
step. According to the view, the majority of transition across four
states occur before the age of 60 months. There are, however, a few
outliers who show slow progression, which could be interesting to
look at in detail. In combination with Feature Matrix, the selected
subcohort shows a specific pattern of incrementally adding three
IAs, in the order of IAA, IA-2A, and GADA, throughout states 4, 5,
and 6, respectively. Pathway Waterfall shows an overview of state
transition patterns and individual subjects’ patterns at the same time.
2.3 Interactive Cohort Construction
State Sequence Finder is a way researchers can freely define and
refine queries to create a cohort based on state transition patterns. As
Fig. 1 shows, the view includes a canvas, where they can graphically
describe state transitions they are looking for. To increase the cus-
tomizability, the view also allows them to specify attributes related
to states (nodes) and transitions between them (edges). For example,
the current view shows four nodes, namely representing state 4, 5,
6, and 7. To further specify state transitions, users currently added
restrictions on state 4 to be the initial state and state 7 to be the final
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state, which filters out other subjects. This view can help clinical
researchers to test their hypotheses about state transitions by con-
structing and comparing multiple subcohorts. The subcohorts can be
available for clinicians in Subgroup List.
2.4 Individual Subject Inspection
Subject List View allows users to see details of subjects’ visits over
time and to show summary of health outcomes for selected subjects
as Figure 1 shows. The view shows Dual Kernel Densities View,
which provides probability density diagrams for selected health out-
comes. For example, clinical researchers chose two health outcomes:
seroconversion (purple, below) and onset (red, above). These two
density diagrams show the distribution of age when they show symp-
toms and get diagnosed at the same time. This view is particularly
useful to evaluate whether specific subcohorts show fast or slow dis-
ease progression. Subject List View also provides a list of subjects’
observations as dots (visits) over a timeline. Each dot represents a
visit, which are color-coded based on the corresponding state. This
view also shows posterior probabilities of state assignment for every
visit, which can show additional details of HMM outcomes. This
view allows users to see heterogeneity of state transition patterns by
inspecting individual subjects’ data in detail.
3 DISCUSSION & CONCLUSIONS
HMMs can provide various outcomes that are useful for clinical
research on observational data. In particular, HMMs reveal latent
states and their transitions from a set of observed variables in an
unsupervised manner. It is often difficult to understand the complex
relationship between the states and observed variables. DPVis ex-
plains the relationship between latent states and observed variables
transparently. Visual summary of states and their transition remind
researchers of what the outputs are with the observed variables,
which are familiar to them in the disease domain. Showing a sum-
mary of relationship between inputs and outputs can help researchers
to understand the models in context of their clinical domains.
Clinical researchers build and test hypotheses iteratively by com-
paring different subject cohorts. The cohorts are often challenging
to describe when using sophisticated criteria for grouping patients;
DPVis provides various ways to build cohorts using all views and
allows direct construction and refinement of queries using State
Sequence Finder, setting intuitive filtering actions on any views.
The flexible methods for constructing filters was useful for clinical
experts to formulate and test their hypotheses. The features empower
researchers to test their hypotheses without leaving the tool because
they construct cohorts and compare the patterns out of those cohorts
visually. Subgroup List enables users to maintain and share such co-
horts with colleagues as they iteratively refine their analysis. Using
these features, researchers generated clinically useful insights for
potential future publication in clinical journals [2].
DPVis provides an overview and details of individual subjects’
records in a single application. Summaries are helpful, and details
are, too. Multiple, coordinated, and interactive visualizations inte-
grated into a single system like DPVis make it possible to see details
without losing the context of overview. Clinical researchers have
extensive knowledge about individual subjects, which may not be
captured in the dataset. Visualizations in various abstraction levels
can help clinical researchers make sense of patterns in light of their
domain knowledge more easily. It is especially useful to translate
experts’ feedback into model iterations. For instance, DPVis helps
users to estimate the usefulness of the model instance and helps them
make decisions whether they should adjust the number of states for
next iterations. To achieve the goal, visual analytics applications for
clinical research need to provide multiple levels of information.
There is great potential in application of AI and machine learning
(ML) algorithms to discover hidden patterns and new knowledge
out of longitudinal health data. It can help clinicians to make break-
through in the field of medicine. Yet, the challenges are to make
such AI and ML algorithms useful for their research. To leverage
clinicians’ domain expertise fully, the system needs to continuously
tap into their expert knowledge. This demo shows the usefulness
of interactive visualizations in human-centered AI for clinical re-
search by making patterns more transparent and by allowing them
researchers to interactively test their hypotheses. How can we extend
this approach for other scenarios and tasks (e.g., predictive model-
ing) in data analysis? There’s no single right answer to this question.
It is necessary for clinicians, ML researchers, and visualization re-
searchers to collaboratively explore the uncharted areas.
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